The National Headache Foundation is providing the below information on this study as a public service to its members.
Theranica is currently conducting a clinical study with Nerivio Migra, a drug-free device for the acute treatment of migraine.
Eligible patients are people with migraine between the ages of 16 and 75 with two to eight migraines per month. Patients can continue to take their regular preventative medications (or preventative devices) during the course of the study. Only two visits to the clinic are required during the study—one at the beginning for enrollment and another at the completion of the study.
This study is currently being conducted at four sites in the U.S. The following locations are looking for participants:
- Albany, New York
- Great Neck (Long Island), New York
- Hartford, Connecticut
- Washington, D.C.
Patients who are interested in participating are invited to send an email to Dr. Solli Brawer (firstname.lastname@example.org) indicating their age, gender, average number of migraine attacks per month, preferred site, email address, and phone number.